Marc has served on the Board of the Company since November 2015. He is a veterinary doctor and was a research director of the National Centre for Scientific Research (CNRS), before joining the Institut Mérieux in 2013 as Vice President in charge scientific and medical affairs. He began his career in 1983 in the field of transplantation immunology in Nantes, then at the Massachusetts Institute of Technology (Cambridge, MA) in Prof. Susumu Tonegawa’s team (1987 Nobel Prize for Physiology and Medicine). From 1990 to 2013, Marc Bonneville led a research group working on human cellular immune responses within UMR892 INSERM (Nantes), that he directed for 17 years. He co-founded the biotech company Innate Pharma SA in 1999, which develops immunotherapeutic approaches in oncology and infectious diseases that target innate lymphocytes and their receptors. Marc is the author of over 200 publications and eight patents and has won several awards and recognitions (bronze and silver medal of CNRS, Halpern’s prize, Foundation for Medical Research and League against Cancer, etc.). He has been involved in about thirty committees and scientific boards, and was an advisor to the Director General of INSERM from 2000 to 2007 in the areas of immunology, infectious diseases and biotherapies.

Scientific and medical affairs, Human cellular immune response